Menopause treatment market size was $17.2 billion in 2024 and is growing at a CAGR of 6.1% during the forecast period (2025-2035). The growing ecosystem of digital care across the globe as they improve access and continuity accessing patients to seek timely and appropriate treatment is expected to drive the market significantly during the forecast period. The rising telehealth and digital platforms for women during menopause to access consultations, education, and treatment more conveniently further drive the market growth. For instance, in February 2025, Carrot Fertility announced telemedicine for menopause. It offers benefits such as saving members time, reducing costs, accessing care, and receiving essential medications without the need to attend in-person appointments. In addition,
Browse the full report description of “Menopause Treatment Market Size, Share & Trends Analysis by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/menopause-market
The key players in the menopause treatment market include Abbott Laboratories, Bayer AG, Merck & Co., Inc., Pfizer Inc., AbbVie, and Novartis AG, among others. Such companies in the menopause market are at the forefront of innovation, continuously advancing treatment solutions and exploring new product applications to better address women's evolving health needs. For instance, in October 2024, Olly launched a menopause support supplement. The company expanded its product line with Mellow Menopause to manage symptoms such as hot flashes, night sweats, mood, fatigue, and sleep challenges.
Market Coverage
• The market number available for – 2024-2035
• Base year- 2024
• Forecast period- 2025-2035
• Segment Covered-
o By Treatment
o By Route of Administration
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape Abbott, Bayer AG, Merck & Co., Inc., Pfizer Inc., AbbVie, and Novartis AG, among others.
Key questions addressed by the report.
Global Menopause Treatment Market Report Segment
By Treatment
By Route of Administration
By Distribution Channel
Global Menopause Treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/menopause-market